Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28067838 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL28243312 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL5081913 | 0.94 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL4940740 | 0.94 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL6400899 | 0.94 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL1539029 | 0.94 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL3953253 | 0.94 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL15391803 | 0.94 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL35911 | 0.94 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL4303578 | 0.94 | CA2 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6864232-B1 | Agent for treating visual cell function disorder | SUCAMPO AG (CH) | 2005-03-08 | — | — | US | disclosed |
| EP-1140134-A1 | AGENT FOR TREATING VISUAL CELL FUNCTION DISORDER | R-Tech Ueno, Ltd. (JP) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000038703-A1 | AGENT FOR TREATING VISUAL CELL FUNCTION DISORDER | R-TECH UENO, LTD. (JP) | 2000-07-06 | — | — | WO | disclosed |